FDA Inspection 1119692 — John Theurer Cancer Center at Hackensack University Medical Center
The FDA completed an inspection of John Theurer Cancer Center at Hackensack University Medical Center on February 25, 2020 in Hackensack, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 25, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hackensack, NJ (United States)
Additional Details
Clinical BA/BE